MasterPharm Recalls Minoxidil/Biotin Capsules Due to Processing Control Deficiencies
MasterPharm LLC is recalling Minoxidil/Biotin 1.25mg/5mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
MasterPharm LLC is voluntarily recalling Minoxidil/Biotin 1.25mg/5mg Capsules, 90 capsules per bottle, in the United States. The recall was initiated because of a lack of processing controls, which means there is a lack of assurance that the product conforms to its specifications.
The affected product is distributed nationwide. The specific lot code is 03-03-2020:42@13, with a best-use date of 8/30/2020. The quantity involved is 300 capsules.
Consumers who have purchased this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for further instructions or a refund.
The recalled product
- Product
- Minoxidil/Biotin 1.25mg/5mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 03-03-2020:42@13
- BUD 8/30/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · quality control deficiency
See all →- ModerateZonisamide Capsules USP recalled for quality control system deviation
FDA (Drugs) · 2022-06-01
- ModerateSteris InnoWave Sonic Irrigator Recalled for Unclear Installation Test Criteria
FDA (Devices) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Tadalafil 7 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- SevereMasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
FDA (Drugs) · 2020-07-08
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- ModerateBetahistine 16 mg Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- SevereMIC+Methyl B12 Injection Recalled for Lack of Processing Controls
FDA (Drugs) · 2021-09-22
- HighLupin Recalls Lisinopril 5 mg Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-06-17
- SevereReliable Compounding Pharmacy Recalls Biotin Capsules Due to Labeling Error
FDA (Drugs) · 2016-07-13